Community Medicine (PSM) · National Health Programmes (NTEP, NVBDCP, NACP, NIS, RMNCH+A)

Under the National Vector Borne Disease Control Programme (NVBDCP), which of the following is the drug of choice for treatment of severe malaria in adults?

  • A Chloroquine
  • B Mefloquine
  • C Artesunate
  • D Primaquine
Correct answer: C. Artesunate

Explanation

Under NVBDCP, artesunate is the drug of choice for severe malaria in adults. It is given parenterally (intravenous or intramuscular) and has been shown to reduce mortality compared to quinine. Chloroquine is not used for severe malaria due to resistance. Mefloquine is not recommended for severe malaria. Primaquine is used for radical cure of vivax malaria, not severe disease.

Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More National Health Programmes (NTEP, NVBDCP, NACP, NIS, RMNCH+A) MCQs

See all National Health Programmes (NTEP, NVBDCP, NACP, NIS, RMNCH+A) MCQs →